2nd Quarter - Report

AMERICAN COLLEGE OF OBSTETRICIANS AND GYNECOLOGISTS for AMERICAN COLLEGE OF OBSTETRICIANS AND GYNECOLOGISTS

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$420,234
Expense method
C: businesses, Internal Revenue Code section 162(e)

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
2nd Quarter - Report (this page) Jul 22, 2019 $420,234 Replaced
2nd Quarter - Amendment Jul 30, 2021 $420,234 Yes

What was lobbied

8 issue areas, each in the filer's own words, with who lobbied on it and where.

Veterans VET

Womens Health Research (general); Assisted Reproductive Technology (general); Gender based health services (general); Provider scope of practice (general); Military Sexual Trauma (general); Abortion (general); Department of Veterans Affairs Medical and Prosthetic Research program (VA),

LobbyistCovered position, as disclosed
TATIANA CALDERON New —
LUCIA DIVENERE —
MALLORY SCHWARZ —
RACHEL TETLOW —

Contacted: Defense, Dept of (DOD); Office of Management & Budget (OMB); SENATE; Health Resources & Services Administration (HRSA); U.S. Agency for International Development (USAID); Executive Office of the President (EOP); State, Dept of (DOS); Homeland Security, Dept of (DHS); HOUSE OF REPRESENTATIVES; Substance Abuse & Mental Health Services Administration (SAMHSA); Environmental Protection Agency (EPA); Indian Health Service; White House Office; Justice, Dept of (DOJ); Natl Institutes of Health (NIH); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Veterans Affairs, Dept of (VA); Centers For Disease Control & Prevention (CDC); Health & Human Services, Dept of (HHS); Agency for Healthcare Research & Quality (AHRQ); Office of Natl Drug Control Policy (NDCP)

Defense DEF

Congressionally Directed Medical Research Programs (CDMRP); Ovarian cancer research (general); Gynecologic cancer (general); Contraception Access (general); Emergency Contraception (general); Military Sexual Trauma (general); Military Womens Health (general); Maternal Mortality and Morbidity (general); Postpartum care (general); Assisted Reproductive Technology (general); H.R. 2091/S. 1049, Access to Contraception for Women Servicemembers and Dependents Act; H.R. 2500/S. 1790/National Defense Authorization Act for Fiscal Year 2020.

LobbyistCovered position, as disclosed
TATIANA CALDERON New —
LUCIA DIVENERE —
MALLORY SCHWARZ —
RACHEL TETLOW —

Contacted: State, Dept of (DOS); Health Resources & Services Administration (HRSA); Office of Management & Budget (OMB); Natl Institutes of Health (NIH); U.S. Agency for International Development (USAID); Homeland Security, Dept of (DHS); Veterans Affairs, Dept of (VA); Justice, Dept of (DOJ); Agency for Healthcare Research & Quality (AHRQ); Office of Natl Drug Control Policy (NDCP); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Environmental Protection Agency (EPA); Substance Abuse & Mental Health Services Administration (SAMHSA); Defense, Dept of (DOD); Centers For Disease Control & Prevention (CDC); White House Office; Executive Office of the President (EOP); Indian Health Service; SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Bills named: S. 1049 (116th), H.R. 2091 (116th), H.R. 2500 (116th), S. 1790 (116th)

Medicare/Medicaid MMM

Childrens Health Insurance Program (CHIP); Implementation of P.L. 114-10, Medicare Access and CHIP Reauthorization Act of 2015; Medicaid (general); Medicare (general); Medicare reimbursement (general); Health Care Reform (general); Medicaid DSH Payments (general); H.R. 3107, Improving Seniors Timely Access to Care Act; H.R. 3302, Keep Physicians Serving Patients Act

LobbyistCovered position, as disclosed
TATIANA CALDERON New —
LUCIA DIVENERE —
MALLORY SCHWARZ —
RACHEL TETLOW —

Contacted: SENATE; Office of Natl Drug Control Policy (NDCP); Centers For Disease Control & Prevention (CDC); Veterans Affairs, Dept of (VA); HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); Food & Drug Administration (FDA); Health Resources & Services Administration (HRSA); Centers For Medicare and Medicaid Services (CMS); Homeland Security, Dept of (DHS); Indian Health Service; Defense, Dept of (DOD); White House Office; U.S. Agency for International Development (USAID); Executive Office of the President (EOP); Substance Abuse & Mental Health Services Administration (SAMHSA); Justice, Dept of (DOJ); Office of Management & Budget (OMB); Agency for Healthcare Research & Quality (AHRQ); State, Dept of (DOS); Environmental Protection Agency (EPA); Health & Human Services, Dept of (HHS)

Bills named: H.R. 3302 (116th), H.R. 3107 (116th)

Budget/Appropriations BUD

Funding for National Institutes of Health (NIH); Health Resources and Services Administration (HRSA); Centers for Disease Control and Prevention (CDC); Agency for Healthcare Research and Quality (AHRQ); American Indian/Alaska Native Womens Health (IHS); International Family Planning; Health Disparities (HHS); Safe Motherhood (CDC); Global Maternal and Child Health (USAID); Maternal Morbidity and Mortality (CDC, HRSA); Maternal Therapeutics Research and Regulation (HHS, NIH, FDA); Reproductive Health (general); Womens Health Research (NIH); Gun Violence Research (CDC); HIV Prevention (DASH); Medicaid and Medicare (CMS); Division of Reproductive Health (CDC); Pregnancy Risk Assessment Monitoring System (CDC); National Center on Birth Defects and Developmental Disabilities (CDC); National Center for Environmental Health (CDC); Public Health Surveillance (general); National Health Service Corps (HRSA); Substance Use Disorder Treatment (SAMHSA); Office on Smoking and Health (CDC); Title V Block Grant (HRSA); Title X Family Planning Program (OPA); Teen Pregnancy Prevention Program (OAH); Screening and Treatment for Maternal Depression (HHS); Endometriosis (NIH, CDC); Center for Primary Care Research (AHRQ); public health surveillance (CDC); WIC Breastfeeding Peer Counselor Program (Ag); H.R. 2740, Labor, Health and Human Services, Education, Legislative Branch, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020; S.___ Labor, Health and Human Services, Education Appropriations Act.

LobbyistCovered position, as disclosed
TATIANA CALDERON New —
LUCIA DIVENERE —
MALLORY SCHWARZ —
RACHEL TETLOW —

Contacted: Agency for Healthcare Research & Quality (AHRQ); Health & Human Services, Dept of (HHS); Indian Health Service; HOUSE OF REPRESENTATIVES; Homeland Security, Dept of (DHS); U.S. Agency for International Development (USAID); Substance Abuse & Mental Health Services Administration (SAMHSA); Executive Office of the President (EOP); State, Dept of (DOS); Environmental Protection Agency (EPA); Veterans Affairs, Dept of (VA); Office of Management & Budget (OMB); Defense, Dept of (DOD); Centers For Disease Control & Prevention (CDC); Office of Natl Drug Control Policy (NDCP); SENATE; Natl Institutes of Health (NIH); Food & Drug Administration (FDA); Justice, Dept of (DOJ); Centers For Medicare and Medicaid Services (CMS); Health Resources & Services Administration (HRSA); White House Office

Bills named: H.R. 2740 (116th)

Government Issues GOV

Family planning (general); Maternal health (general). H.R. 1581/S. 707, Reproductive Rights are Human Rights; H.R. 1055/S. 368, Global Health, Empowerment and Rights Act

LobbyistCovered position, as disclosed
TATIANA CALDERON New —
LUCIA DIVENERE —
MALLORY SCHWARZ —
RACHEL TETLOW —

Contacted: Justice, Dept of (DOJ); Office of Management & Budget (OMB); Veterans Affairs, Dept of (VA); Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); Environmental Protection Agency (EPA); White House Office; Natl Institutes of Health (NIH); SENATE; Office of Natl Drug Control Policy (NDCP); Centers For Disease Control & Prevention (CDC); Agency for Healthcare Research & Quality (AHRQ); Centers For Medicare and Medicaid Services (CMS); Indian Health Service; Food & Drug Administration (FDA); State, Dept of (DOS); Substance Abuse & Mental Health Services Administration (SAMHSA); HOUSE OF REPRESENTATIVES; Health Resources & Services Administration (HRSA); Homeland Security, Dept of (DHS); U.S. Agency for International Development (USAID); Defense, Dept of (DOD)

Bills named: H.R. 1581 (116th), S. 368 (116th), H.R. 1055 (116th), S. 707 (116th)

Immigration IMM

Immigration and womens health (general); Health care work force (general); Abortion (general); Pregnant women in immigration detention; H.R. 3239, Humanitarian Standards for Individuals in Customs and Border Protection Custody Act; H.R. 3563/S. 648, Stop Shackling and Detaining Pregnant Women Act

LobbyistCovered position, as disclosed
TATIANA CALDERON New —
LUCIA DIVENERE —
MALLORY SCHWARZ —
RACHEL TETLOW —

Contacted: Indian Health Service; Substance Abuse & Mental Health Services Administration (SAMHSA); HOUSE OF REPRESENTATIVES; Defense, Dept of (DOD); Office of Management & Budget (OMB); White House Office; Executive Office of the President (EOP); SENATE; Justice, Dept of (DOJ); Office of Natl Drug Control Policy (NDCP); Health Resources & Services Administration (HRSA); Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC); Centers For Medicare and Medicaid Services (CMS); Agency for Healthcare Research & Quality (AHRQ); State, Dept of (DOS); Environmental Protection Agency (EPA); Natl Institutes of Health (NIH); U.S. Agency for International Development (USAID); Veterans Affairs, Dept of (VA); Homeland Security, Dept of (DHS); Health & Human Services, Dept of (HHS)

Bills named: H.R. 3239 (116th), H.R. 3563 (116th), S. 648 (116th)

Environment/Superfund ENV

Implementation of P.L. 114-182, Frank R. Lautenberg Chemical Safety for the 21st Century Act; H.R. 1243/S. 523, Climate Change Health Protection and Promotion Act;

LobbyistCovered position, as disclosed
TATIANA CALDERON New —
LUCIA DIVENERE —
MALLORY SCHWARZ —
RACHEL TETLOW —

Contacted: HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); Agency for Healthcare Research & Quality (AHRQ); White House Office; U.S. Agency for International Development (USAID); Indian Health Service; Justice, Dept of (DOJ); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Veterans Affairs, Dept of (VA); SENATE; Defense, Dept of (DOD); Environmental Protection Agency (EPA); Health & Human Services, Dept of (HHS); Natl Institutes of Health (NIH); Office of Natl Drug Control Policy (NDCP); State, Dept of (DOS); Homeland Security, Dept of (DHS); Substance Abuse & Mental Health Services Administration (SAMHSA); Health Resources & Services Administration (HRSA); Executive Office of the President (EOP); Office of Management & Budget (OMB)

Bills named: S. 523 (116th), H.R. 1243 (116th)

Health Issues HCR

Health Insurance Coverage (general); Health Disparities (general); Breastfeeding (general); Assisted Reproductive Technology (general); Smoking Cessation (general); Substance Use Disorder (general); Gynecologic Cancer (general); Gynecologic Devices (general); Reproductive Health (general); Intimate Partner Violence (general); Gun Violence (general); Immunization (general); Breast Cancer (general); E-Cigarettes (general); Medical Liability Reform (general); Health IT (general); Patient-Physician Relationship (general); Conscience Refusals (general); Child Welfare (general); Prematurity (general); Maternal Mortality and Morbidity (general); Graduate Medical Education (general); Contraception (general); Abortion (general); Indian Health (general); Teaching Health Centers (general); Sexuality Education (general); Teen Pregnancy Prevention Program (general); Personal Responsibility Education Program (general); Research in Pregnant and Breastfeeding Women (general); Health Care Reform (general); Title X Family Planning Program (general); Womens Preventive Services (general); Drug Pricing (general); Administrative Burden (general); Surprise Billing (general); Pediatric Loan Repayment Program (general); H.R. 1551/S.1960, Quality Care for Moms and Babies Act; H.R. 1897/S. 916, MOMMAs Act; H.R. 1763/S. 348, Resident Physician Shortage Reduction Act of 2019; H.R. 1554, Resident Education Deferred Interest Act; H.R.___/S. 116, MOMS Act; S.___, Rural MOMS Act; H.R. 2778/S. 1481, Healthy MOM Act; H.R. 2902/S. 1600, Maternal CARE Act; H.R. 2602/S. 1343, MOMMIES Act; H.R. 1585/S.___, Violence Against Women Reauthorization Act of 2019; S. 130/S. 311, Born-Alive Abortion Survivors Protection Act; H.R. 784/S. 160, Pain-Capable Unborn Child Protection Act; H.R. 2975/S. 1645, Womens Health Protection Act; H.R. 986/S. 466, Protecting Americans with Preexisting Conditions Act; H.R. 1010, To provide that the rule entitled "Short-Term, Limited Duration Insurance" shall have no force or effect; H.R. 1143, Educating Consumers on the Risks of Short-Term Plans Act of 2019; S.Res. 29, A resolution expressing support for the designation of a Womens Health Research Day; H.R. 2815/S. 304/S. 1191, Training the Next Generation of Primary Care Doctors Act of 2019; H.R.__/S.__, Wise Investment in our Children Act; H.Res. 317/S.Res. 154, A resolution recognizing Black Maternal Health Week; H.R. 2689/S. 1438, Breast Cancer Research Stamp Reauthorization Act; S. 1895, Lower Health Care Costs Act; H.R. 2862/S. 1619, VACCINES Act; H.R. 3296/S. 1847, Affordability is Access Act; H.R. 2777/S. 1936, Protecting Access to Lifesaving Screenings Act; H.R. 3109, GEDI Act; H.R. 2803/S. 1461, Access to Infertility Treatment and Care Act; H.R. 2411/S. 1258, Tobacco to 21 Act; implementation of P.L. 115-344, Preventing Maternal Deaths Act; implementation of P.L. 115-320, Improving Access to Maternity Care Act

LobbyistCovered position, as disclosed
TATIANA CALDERON New —
LUCIA DIVENERE —
MALLORY SCHWARZ —
RACHEL TETLOW —

Contacted: Substance Abuse & Mental Health Services Administration (SAMHSA); Office of Natl Drug Control Policy (NDCP); Defense, Dept of (DOD); Indian Health Service; Centers For Disease Control & Prevention (CDC); Justice, Dept of (DOJ); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); White House Office; U.S. Agency for International Development (USAID); State, Dept of (DOS); Office of Management & Budget (OMB); Health Resources & Services Administration (HRSA); Environmental Protection Agency (EPA); Veterans Affairs, Dept of (VA); SENATE; Homeland Security, Dept of (DHS); Agency for Healthcare Research & Quality (AHRQ); HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); Executive Office of the President (EOP); Food & Drug Administration (FDA)

Bills named: H.R. 1143 (116th), H.R. 2975 (116th), S. 1438 (116th), H.R. 2689 (116th), H.R. 1551 (116th), H.R. 1585 (116th), S. 1481 (116th), S. 311 (116th), S. 1461 (116th), S. 348 (116th), H.R. 1554 (116th), S. 916 (116th), S. 1343 (116th), S. 1960 (116th), H.R. 3109 (116th), S. 1847 (116th), S. 1895 (116th), H.R. 1763 (116th), S. 304 (116th), S. 466 (116th), H.R. 986 (116th), S. 1600 (116th), H.R. 2778 (116th), S. 160 (116th), H.R. 2803 (116th), H.R. 2902 (116th), H.R. 2862 (116th), H.Res. 317 (116th), H.R. 2411 (116th), S. 130 (116th), S. 1645 (116th), S. 1258 (116th), S. 1936 (116th), S.Res. 154 (116th), H.R. 1897 (116th), H.R. 2777 (116th), H.R. 1010 (116th), H.R. 2602 (116th), S. 1191 (116th), S. 1619 (116th), H.R. 3296 (116th), H.R. 784 (116th), S. 116 (116th), S.Res. 29 (116th), H.R. 2815 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.